A Novel Blood Index-Based Model to Predict Hepatitis B Virus-Associated Hepatocellular Carcinoma Recurrence After Curative Hepatectomy: Guidance on Adjuvant Transcatheter Arterial Chemoembolization Choice
Open Access
- 24 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11, 755235
Abstract
Background: Postoperative recurrence is a significant obstacle in hepatocellular carcinoma (HCC) treatment. This study aimed to construct a blood index-based model to predict hepatitis B virus-associated HCC (HBV-HCC) recurrence after curative hepatectomy. Methods: A total of 370 patients who received initially curative hepatectomy for HBV-HCC were included in this study. A novel blood index signature (BIS) was identified and systematically analyzed for its recurrence predictive value. Following this, multivariate Cox regression analysis was performed to build a blood index-based nomogram. Results: A BIS based on the aminotransferase-to-platelet ratio index and a systemic inflammatory response index was used to construct a nomogram. The model showed good clinical applicability and reliability. Notably, the patients in the high recurrence risk group tended to benefit from adjuvant transcatheter arterial chemoembolization (TACE). Conclusion: A reliable model was constructed to predict the HBV-HCC recurrence after curative hepatectomy. This model can guide the surgeons in selecting patients with high recurrence risk patients who may benefit from adjuvant TACE.Keywords
This publication has 35 references indexed in Scilit:
- Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomyHepatobiliary & Pancreatic Diseases International, 2016
- A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular CarcinomaAnnals of Surgery, 2016
- Recurrence of Hepatocellular Cancer After ResectionAnnals of Surgery, 2015
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centersHepatology, 2012
- A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)British Journal of Cancer, 2012
- Obesity, inflammation, and liver cancerJournal of Hepatology, 2012
- Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombusThe American Journal of Surgery, 2009
- Selecting a Short-term Prognostic Model for Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2009
- Recurrence of Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Inflammation and cancer: back to Virchow?The Lancet, 2001